Plants of the genus Schisandra (Schisandraceae) are known to be rich sources of lignans, and lanostane and cycloartane triterpenes, which have been found to possess various beneficial pharmacological effects [1] . S. bicolor Cheng var. tuberculata Law, widely distributed in southwest China, has been reported to contain lignans and triterpenoids [2a,2b] . In our study of bioactive compounds from S. bicolor, we have reported some lignans [2c] . Further investigation led to the isolation of a new dibenzylbutane lignan, named schibicolignan A (1) , and five known lignans, bis [dibenzylbutane] (2) [2d], machilin A (3) [3a] , macelignan (4) [3b], saururenin (5) [3c] and sphenanlignan (6) [3d] . disappearance of the hydroxyl group at C-4" of 1, which defined a 1,3,5 tri-substituted aromatic ring (ring B'). The key HMBC correlations ( Figure B ) recorded between C-3' (δ C 150.3) and both H-2' (δ H 6.64) and a broad singlet at δ H 5.95 (4'-OH), as well as HMBC correlations exhibited between C-5' (δ C 138.2) and the same broad singlet at δ H 5.95 (4'-OH) and H-6' (δ H 6.61) , unambiguously located a methoxy group (δ H 3.88 and δ C 56.1) on C-3'. The guaiacyl nucleus (ring B) was confirmed by HSQC and HMBC correlations ( Figure B ) exhibiting two methine peaks at δ C 112.6 (C-2') and δ C 121.8 (C-6'). Comparison of the 13 C NMR spectral data for C-7 (7ʹʹʹ) and C-9 (9ʹʹʹ) with those of the related lignan argenteane [4] allowed assignment of the erythro form to both aliphatic chains of compound 1 and the relative configuration (8R, 8'S, 8"S, 8"'R) was thus consistent with erythro argenteane ( Figure A) .
The results of the reducing potential (transformation of Fe 3+ -Fe 2+ ) of the standard (ascorbic acid) and compounds 1-6 are shown in Table 2 . The antioxidant activity of compound 4 was significantly higher than those of the other five compounds and ascorbic acid at the same concentrations. 
Extraction and isolation:
The dried stems of S. bicolor (15 kg) were extracted with ethanol (95%). Ethanol was evaporated in vacuo to afford a syrupy residue that was suspended in distilled water and fractionated successively with light petroleum, ethylacetate, and H 2 O. The light petroleum soluble portion (90 g) was subjected to CC on silica gel, using light petroleum/acetone (from 10:0 to 0:10) as eluent to give 7 fractions (Fr 1 -Fr 7 ). Fr 2 (10 g) was subsequently purified over columns of silica gel to afford 6 subfractions (Fr 2-1 -Fr 2-6 ). Fr 2-1-4 was further fractionated on a Sephadex LH-20 column with CHCl 3 /MeOH (1:1), and then subsequently purified over columns of silica gel to afford 4 subfractions (Fr 2-1-4-1 -Fr 2-1-4-4 ). Fr 2-1-4-2 was similarly treated, but with CHCl 3 /MeOH (1:3) as eluant, and then produced 5 (6.1 mg) by preparative TLC with light petroleum/ethyl acetate/ CHCl 3 (20:5:2) as developing solvent. Fr 3 (7 g) was subsequently purified over columns of silica gel to afford 8 subfractions (Fr 3-1 -Fr 3-8 ). Fr 3-2 was followed by Sephadex LH-20 CC with CHCl 3 /MeOH (1:1), and then subsequently purified over columns of silica gel to afford 4 subfractions (Fr 3-2-1 -Fr 3-2-4 ). Fr 3-2-2 was subjected to Sephadex LH-20 CC with CHCl 3 /MeOH (1:3) , followed by PTLC with light petroleum/ethyl acetate (2:1) to produce 1 (5.2 mg) . Fr 3-8 was further fractionated by Sephadex LH-20 CC with CHCl 3 /MeOH (1:1), and then subsequently purified over columns of silica gel to afford 4 subfractions (Fr 3-8-1 -Fr 3-8-4 ). Fr 3-8-2 was subjected to Sephadex LH-20 CC with CHCl 3 /MeOH (1:3); Fr 3-8-2-2 then produced 2 (10.2 mg) by CC with light petroleum/ethyl acetate (4:1), while Fr 3-8-2-1 produced 4 (15.2 mg) by PTLC with light petroleum/ethyl acetate (2:1). Fr 4 (5 g) was subsequently purified by silica gel CC to afford 8 subfractions (Fr 4-1 -Fr [4] [5] [6] [7] [8] ). Fr 4-3 was subjected to Sephadex LH-20 CC with CHCl 3 /MeOH (1:1), and then was subsequently purified over columns of silica gel to afford 4 subfractions (Fr 4-3-1 -Fr 4-3-4 ); Fr 4-3-2 produced 6 (4.3 mg) by Sephadex LH-20 CC with MeOH. Fr was fractionated by Sephadex LH-20 CC with CHCl 3 /MeOH (1:1), and then subsequently purified over columns of silica gel to afford 4 subfractions (Fr 4-4-1 -Fr 4-4-4 ); Fr 4-4-2 was subsequently purified over a column of silica gel to afford 4 subfractions (Fr 4-4-2-1 -Fr 4-4-2-3 ). Fr 4-4-2-2 then produced 3 (7.2 mg) by PTLC with light petroleum/ethyl acetate (2:1) as developing solvent.
Schibicolignan A (1) Yellowish oil.
[α] 20 D : +4.28 (c 0.35, CHCl 3 ). IR v max (KBr): 3450, 1849, 1735, 1615, 1514, 1495, 1483, 1437, 1372, 1247, 1021 and 923 cm -1 . UV λ max (MeOH) nm (log ε): 220 (3.91), 239 (3.85), 289 (3.73). 1 H NMR and 13 C NMR: Table 1 . HRMS-EI: m/z 638.3240 [M + ] (calcd. for C 40 H 46 O 7 : 638.3244).
Antioxidant activity:
The total reducing power was determined according to the method described previously [5] .
